Unternehmen
HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH
HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH – Unternehmen mit Aktivitäten in Forschung und Innovation.
Forschungsprojekte
- Deciphering commensal-host-pathogen metabolic interactions to combat intestinal infections Our intestinal tract offers an attractive environment for bacteria. The beneficial bacteria of our microbiota…
- Understanding the individual host response against Hepatitis D Virus to develop a personalized approach for the management of hepatitis D Hepatitis D is by far the most severe form of chronic viral hepatitis frequently leading to liver failure, he…
- Biodiversity Conservation to Mitigate the risks of emerging infectious diseases Biodiversity loss in hotspots of biodiversity is, among other socio-ecological factors, key to understand, pr…
- Interrogating RNA-protein interactions underlying SARS-CoV-2 infection and antiviral defense The global COVID-19 pandemic underscores the need to better understand its causative agent, SARS-CoV-2, and t…
- Training AlliancE for Novel Microbiome-Modulating TherapieS TALENTS aims to build up an international programme for interdisciplinary and transsectorial training of 15 d…
- Integrated Services for Infectious Disease Outbreak Research The ISIDORe consortium, made of the capacities of European ESFRI infrastructures and coordinated networks, pr…
- Strategies and Technologies for United and Resilient Critical Infrastructures and Vital Services in Pandemic-Stricken Europe The COVID-19 pandemic has highlighted the importance of the continuity of vital services, has shown the need…
- Impact and viability of a novel mass PCR testing method as a pandemic-fighting strategy The COVID-19 pandemic has not only affected our health, but also our lifestyles and our economies. Given its…
- Design and synthesis of novel inhibitors of the anti-infective target IspE Due to the current antimicrobial resistance crisis, addressing underexplored targets to afford anti-infective…
- NEXT GENERATION VACCINES AGAINST GASTROINTESTINAL MUCOSAL PATHOGENS, USING HELICOBACTER PYLORI AS MODEL PATHOGEN To overcome antimicrobial resistance (AMR) compromising global public health, novel strategies to develop nex…
- Antibiotic Lead Optimization The bacterial sliding clamp (DnaN) is an innovative target for the development of novel antibiotics, which ar…